PIK3CA and colorectal carcinoma: Overactivation of the PI3K/AKT signaling pathway has been reported to play an important role in initiation and progression events such as metastasis, drug resistance, and carcinogenesis of CRC, and is therefore considered a significant therapeutic target [27].